Effect of high-chromium brewer’s yeast on human serum lipids

Journal of the American College of Nutrition

Volumn 1, Issue 3, 1982, Pages 263-274

  Elwood, J C ^a   Nash, D T ^a   Streeten, D H P ^a  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

Brewer s yeast; Chromium; Lipoproteins; Serum lipids

Indexed keywords

CHOLESTEROL; CHROMIUM; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD; FEMALE; HUMAN; HYPERLIPIDEMIA; MALE; YEAST;

ADULT; AGED; CHOLESTEROL; CHROMIUM; FEMALE; HUMAN; HYPERLIPIDEMIA; LIPIDS; LIPOPROTEINS, HDL; LIPOPROTEINS, HDL CHOLESTEROL; MALE; MIDDLE AGE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TRIGLYCERIDES; YEAST, DRIED;

EID: 0020390034     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.1982.10718995     Document Type: Article

References (33)

1. Mertz W, Schwarz K: Relation ot glucose tolerance factor to impaired glucose tolerance in rats on stock diets. Am J Physiol 196:614-618, 1959.
2. Doisy R J: Plasma insulin assay and adipose tissue metabolism. Endocinrology 72:273-278, 1963.
3. Schroeder HA: Diabetic-like serum glucose levels in chromium deficient rats. Life Sei 4: 2057-2062,1965.
4. Davidson IWF, Lang CM, Blackwell WL: Impairment of carbohydrate metabolism of the squirrel monkey. Diabetes 16:395-401, 1967.
5. Davidson IWF, Blackwell WL: Changes in car bohydrate metabolism with chromium dietary supplements. Proc Soc Exp Biol Med 127:6672, 1968.
6. Mertz W: Chromium occurrence and function in biological systems. Physiol Rev 49:169-239, 1969.
7. Anderson RA, Mertz W: Glucose Tolerance Factor: An essential dietary agent. Trends Bio-chem Sei 2:277-279, 1977.
8. Doisy RJ, Jastremski MS, Greenstein FL: Metabolic effects of Glucose Tolerance Factor and trivalent chromium in normal and genetically diabetic mice. Excerpta Med Int Congr Ser (Abstr) 280:155, 1973.
9. Tuman RW, Bilbo JT, Doisy RJ: Comparison and effects of natural and synthetic Glucose Tolerance Factor in normal and genetically diabetic mice. Diabetes 27:49-56, 1978.
10. Jeejeebhoy KN, Chu RC, Marliss EB, Greenberg GR, Bruce-Robertson A: Chromium deficiency, glucose intolerance, and neuropathy reversed by chromium supplementation in a patient receiving long-term total parenteral nutrition. Am J Clin Nutr 30:531, 1977.
11. Freund H, Atamian S, Fisher JE: Chromium deficiency during total parenteral nutrition. JAMA 241:496-498, 1979.
12. Doisy RJ, Streeten DHP, Freiberg JM, Schneider AJ: Chromium metabolism in man and biochemical effects. In Prasad AS (ed): “Trace Elements in Human Health and Disease,” Nutrition Foundation Monograph. New York: Academic Press, 1976, pp 79-101.
13. Freiberg JM, Schneider TR, Streeten DHP, Schneider AJ: Effects of brewers yeast on glucose tolerance. Diabetes (Abstr) 24:433, 1975.
14. Liu VJK, Nordstrom J, Kohrs WB, Lorah E, Dowdy R: Effects of high-chromium yeast-extract supplementation on serum lipids, serum insulin, and glucose tolerance in older women. Fed Proc (Abstr) 36:1123, 1977.
15. Levine RA, Streeten DHP, Doisy RJ: Effects of oral chromium supplementation on the glucose tolerance of elderly human subjects. Metabolism 17:114-125, 1968.
16. Curran GL: Effect of certain transition group elements on hepatic synthesis of cholesterol in the rat. J Biol Chem 210:765, 1954.
17. Schroeder HA, Vincton WJ Jr, Balassa JJ: Effect of chromium, cadmium, and lead on serum cholesterol of rats. Proc Soc Exp Biol Med 109:859, 1962.
18. Schroeder HA: The role of chromium in mammalian nutrition. Am J Clin Nutr 21:230, 1968.
19. Schroeder HA, Nason AP, Tipton IH: Chromium deficiency as a factor in atherosclerosis. J Chron Dis 23:123, 1970.
20. Offenbacher EG, Pi Sunyer FX: Beneficial effect of chromium-rich yeast on glucose tolerance and blood lipids in elderly subjects. Diabetes 29:919-925, 1980.
21. Mertz W: An overview. In Shapcott D, Hubert J (eds): “Chromium in Nutrition and Metabolism.” Amsterdam: Elsevier/North Holland, 1979, pp 1-14.
22. Zlatkis A, Zak B, Boyle A: Rapid estimation of free and total cholesterol. J Lab Clin Med 41:486, 1953.
23. Zak B, Dicerman RC, White EG, Burnett H et al: A new method for the direct determination of serum cholesterol. Am J Clin Pathol 24:1307, 1954.
24. Ishikawa TT, MacGee J, Morrison JA, Gleuck CJ: Quantitative analysis of cholesterol in 5 to 20 /rl of plasma. J Lipid Res 15:286-291, 1974.
25. Burstein M, Sholnick HR, Samaille J: Sur un dosage rapide in cholesterol lie aux alpha et beta-lipoprotein in serum. Clin Chem Acta 5:609, 1960.
26. Burstein M, Sholnick HR, Morfin R: Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res 11:583, 1970.
27. Grover T: Effect of pH on determination of high-density lipoprotein cholesterol by precipitation with phosphotungstate-magnesium. Clin Chem 25:560, 1979.
28. Foreman JR, Karlin JB, Karlin C, Edelstein DJ, et al: Fractionation of human serum lipoproteins by single-spin gradient ultracentrifugation: Quantification of apolipoproteins B and A-l and lipid components. J Lipid Res 18: 759, 1977.
29. Bloom RJ, Elwood JC: Quantitation of lipid profiles from isolated serum lipoproteins using small volumes of human serum. Clin Biochem 14:119-125,198.
30. Lopes-Virella MF, Stone P, Ellis S, Colwell JA: Cholesterol determinations in high-density lipoproteins separated by three different methods. Clin Chem 23:882-884, 1977.
31. Demacher PNM, Vos-Janssen HE, Jijmans AGM, Van’t Laar A, Jansen AP: Measurement of high-density lipoprotein cholesterin in serum: Comparison of six isolation methods combined with enzymatic cholesterol analysis. Clin Chem 26:1780-1786, 1980.
32. Riales R: In Shapcott D, Hubert J (eds): “Chromium in Nutrition and Metabolism.” Amsterdam: Elsevier/North Holland, 1979, pp 199-212.
33. Railes R, Albrink MJ: Effect of chromium chloride supplementation on glucose tolerance and serum lipids including high density lipoprotein of adult men. Am J Clin Nutr 34:2670-2678, 1981.